We further induced the tumor cell lines with long-term, low-dose HDAC inhibitor treatment to establish resistant cell strains H9-R, K299-R, and HUT78-R (Fig. 1E, F and Supplementary Fig. S2D). Here, HDAC9 is linked to neoplasm.